Skip to main content
Erschienen in: Osteoporosis International 6/2013

01.06.2013 | Original Article

The role of community pharmacists in the prevention and management of osteoporosis and the risk of falls: results of a cross-sectional study and qualitative interviews

verfasst von: M.-C. Laliberté, S. Perreault, N. Damestoy, L. Lalonde

Erschienen in: Osteoporosis International | Ausgabe 6/2013

Einloggen, um Zugang zu erhalten

Abstract

Summary

In a mailed survey and qualitative interviews, it was observed that community pharmacists and public health authorities believe that pharmacists should play a significant role in the prevention and management of osteoporosis and the risk of falls. However, pharmacists acknowledge a wide gap between their ideal and actual levels of involvement.

Introduction

The aim of this study was to explore perceptions of community pharmacists and public health authorities regarding the role of pharmacists in providing services in relation to osteoporosis and risk of falls and the barriers to providing them.

Methods

Using a modified five-step version of Dillman’s tailored design method, a questionnaire was mailed to a random sample of 1,250 community pharmacists practicing in Montreal (Quebec, Canada) and surrounding areas. A similar questionnaire was sent to public health officers in these regions. Additionally, telephone interviews were conducted with regional and ministry level public health officers.

Results

Of the 1,250 pharmacists contacted, 28 were ineligible. In all, 571 of 1,222 (46.7 %) eligible community pharmacists and all the public health officers returned the questionnaire. Six public health officers (five regional and one at ministry level) were interviewed. Most pharmacists believed they should be involved in screening for osteoporosis (46.6 %) and risk of falls (50.3 %); however, fewer reported actually being involved in such services (17.4 % and 19.2 %, respectively). In their view, the main barriers to providing these services in current practice were lack of time (78.8 %), lack of clinical tools (65.4 %), and lack of coordination with other healthcare professionals (54.5 %). Public health authorities also thought community pharmacists should play a significant role in providing osteoporosis and fall risk services. However, few community pharmacist-mediated activities are in place in the participating regions.

Conclusions

Although community pharmacists and public health authorities believe pharmacists should play a significant role with regard to osteoporosis and the risk of falls, they acknowledge a wide gap between the ideal and actual levels of pharmacist involvement.
Literatur
1.
Zurück zum Zitat O’Loughlin J, Masson P, Dery V, Fagnan D (1999) The role of community pharmacists in health education and disease prevention: a survey of their interests and needs in relation to cardiovascular disease. Prev Med 28:324–331PubMedCrossRef O’Loughlin J, Masson P, Dery V, Fagnan D (1999) The role of community pharmacists in health education and disease prevention: a survey of their interests and needs in relation to cardiovascular disease. Prev Med 28:324–331PubMedCrossRef
2.
Zurück zum Zitat Paluck EC, Stratton TP, Eni GO (1994) Community pharmacists’ participation in health education and disease prevention activities. Can J Public Health 85:389–392PubMed Paluck EC, Stratton TP, Eni GO (1994) Community pharmacists’ participation in health education and disease prevention activities. Can J Public Health 85:389–392PubMed
3.
Zurück zum Zitat Chandra A, Malcolm N 2nd, Fetters M (2003) Practicing health promotion through pharmacy counseling activities. Health Promot Pract 4:64–71PubMedCrossRef Chandra A, Malcolm N 2nd, Fetters M (2003) Practicing health promotion through pharmacy counseling activities. Health Promot Pract 4:64–71PubMedCrossRef
4.
Zurück zum Zitat Anderson C, Blenkinsopp A, Armstrong M (2009) The contribution of community pharmacy to improving the public’s health: summary report of the litterature review 1990–2007. www.pharmacyhealthlink.org.uk. Accessed 11 August 2011 Anderson C, Blenkinsopp A, Armstrong M (2009) The contribution of community pharmacy to improving the public’s health: summary report of the litterature review 1990–2007. www.​pharmacyhealthli​nk.​org.​uk. Accessed 11 August 2011
5.
Zurück zum Zitat Elliot-Gibson V, Bogoch ER, Jamal SA, Beaton DE (2004) Practice patterns in the diagnosis and treatment of osteoporosis after a fragility fracture: a systematic review. Osteoporos Int 15:767–778PubMedCrossRef Elliot-Gibson V, Bogoch ER, Jamal SA, Beaton DE (2004) Practice patterns in the diagnosis and treatment of osteoporosis after a fragility fracture: a systematic review. Osteoporos Int 15:767–778PubMedCrossRef
6.
Zurück zum Zitat Papaioannou A, Giangregorio L, Kvern B, Boulos P, Ioannidis G, Adachi JD (2004) The osteoporosis care gap in Canada. BMC Musculoskelet Disord 5:11PubMedCrossRef Papaioannou A, Giangregorio L, Kvern B, Boulos P, Ioannidis G, Adachi JD (2004) The osteoporosis care gap in Canada. BMC Musculoskelet Disord 5:11PubMedCrossRef
7.
Zurück zum Zitat Giangregorio L, Papaioannou A, Cranney A, Zytaruk N, Adachi JD (2006) Fragility fractures and the osteoporosis care gap: an international phenomenon. Semin Arthritis Rheum 35:293–305PubMedCrossRef Giangregorio L, Papaioannou A, Cranney A, Zytaruk N, Adachi JD (2006) Fragility fractures and the osteoporosis care gap: an international phenomenon. Semin Arthritis Rheum 35:293–305PubMedCrossRef
8.
Zurück zum Zitat Ashe M, Khan K, Guy P, Kruse K, Hughes K, O’Brien P et al (2004) Wristwatch-distal radial fracture as a marker for osteoporosis investigation: a controlled trial of patient education and a physician alerting system. J Hand Ther 17:324–328PubMedCrossRef Ashe M, Khan K, Guy P, Kruse K, Hughes K, O’Brien P et al (2004) Wristwatch-distal radial fracture as a marker for osteoporosis investigation: a controlled trial of patient education and a physician alerting system. J Hand Ther 17:324–328PubMedCrossRef
9.
Zurück zum Zitat Cranney A, Lam M, Ruhland L, Brison R, Godwin M, Harrison MM et al (2008) A multifaceted intervention to improve treatment of osteoporosis in postmenopausal women with wrist fractures: a cluster randomized trial. Osteoporos Int 19:1733–1740PubMedCrossRef Cranney A, Lam M, Ruhland L, Brison R, Godwin M, Harrison MM et al (2008) A multifaceted intervention to improve treatment of osteoporosis in postmenopausal women with wrist fractures: a cluster randomized trial. Osteoporos Int 19:1733–1740PubMedCrossRef
10.
Zurück zum Zitat Feldstein A, Elmer PJ, Smith DH, Herson M, Orwoll E, Chen C et al (2006) Electronic medical record reminder improves osteoporosis management after a fracture: a randomized, controlled trial. J Am Geriatr Soc 54:450–457PubMedCrossRef Feldstein A, Elmer PJ, Smith DH, Herson M, Orwoll E, Chen C et al (2006) Electronic medical record reminder improves osteoporosis management after a fracture: a randomized, controlled trial. J Am Geriatr Soc 54:450–457PubMedCrossRef
11.
Zurück zum Zitat Lafata JE, Kolk D, Peterson EL, McCarthy BD, Weiss TW, Chen YT et al (2007) Improving osteoporosis screening: results from a randomized cluster trial. J Gen Intern Med 22:346–351PubMedCrossRef Lafata JE, Kolk D, Peterson EL, McCarthy BD, Weiss TW, Chen YT et al (2007) Improving osteoporosis screening: results from a randomized cluster trial. J Gen Intern Med 22:346–351PubMedCrossRef
12.
Zurück zum Zitat Majumdar SR, Rowe BH, Folk D, Johnson JA, Holroyd BH, Morrish DW et al (2004) A controlled trial to increase detection and treatment of osteoporosis in older patients with a wrist fracture. Ann Intern Med 141:366–373PubMedCrossRef Majumdar SR, Rowe BH, Folk D, Johnson JA, Holroyd BH, Morrish DW et al (2004) A controlled trial to increase detection and treatment of osteoporosis in older patients with a wrist fracture. Ann Intern Med 141:366–373PubMedCrossRef
13.
Zurück zum Zitat Majumdar SR, Beaupre LA, Harley CH, Hanley DA, Lier DA, Juby AG et al (2007) Use of a case manager to improve osteoporosis treatment after hip fracture: results of a randomized controlled trial. Arch Intern Med 167:2110–2115PubMedCrossRef Majumdar SR, Beaupre LA, Harley CH, Hanley DA, Lier DA, Juby AG et al (2007) Use of a case manager to improve osteoporosis treatment after hip fracture: results of a randomized controlled trial. Arch Intern Med 167:2110–2115PubMedCrossRef
14.
Zurück zum Zitat Solomon DH, Polinski JM, Stedman M, Truppo C, Breiner L, Egan C et al (2007) Improving care of patients at-risk for osteoporosis: a randomized controlled trial. J Gen Intern Med 22:362–367PubMedCrossRef Solomon DH, Polinski JM, Stedman M, Truppo C, Breiner L, Egan C et al (2007) Improving care of patients at-risk for osteoporosis: a randomized controlled trial. J Gen Intern Med 22:362–367PubMedCrossRef
15.
Zurück zum Zitat Solomon DH, Katz JN, Finkelstein JS, Polinski JM, Stedman M, Brookhart MA et al (2007) Osteoporosis improvement: a large-scale randomized controlled trial of patient and primary care physician education. J Bone Miner Res 22:1808–1815PubMedCrossRef Solomon DH, Katz JN, Finkelstein JS, Polinski JM, Stedman M, Brookhart MA et al (2007) Osteoporosis improvement: a large-scale randomized controlled trial of patient and primary care physician education. J Bone Miner Res 22:1808–1815PubMedCrossRef
16.
Zurück zum Zitat Yuksel N, Majumdar SR, Biggs C, Tsuyuki RT (2010) Community pharmacist-initiated screening program for osteoporosis: randomized controlled trial. Osteoporos Int 21:391–398PubMedCrossRef Yuksel N, Majumdar SR, Biggs C, Tsuyuki RT (2010) Community pharmacist-initiated screening program for osteoporosis: randomized controlled trial. Osteoporos Int 21:391–398PubMedCrossRef
17.
Zurück zum Zitat Laliberte MC, Perreault S, Jouini G, Shea BJ, Lalonde L (2011) Effectiveness of interventions to improve the detection and treatment of osteoporosis in primary care settings: a systematic review and meta-analysis. Osteoporos Int 22:2743–2768PubMedCrossRef Laliberte MC, Perreault S, Jouini G, Shea BJ, Lalonde L (2011) Effectiveness of interventions to improve the detection and treatment of osteoporosis in primary care settings: a systematic review and meta-analysis. Osteoporos Int 22:2743–2768PubMedCrossRef
18.
Zurück zum Zitat Teng GG, Warriner A, Curtis JR, Saag KG (2008) Improving quality of care in osteoporosis: opportunities and challenges. Curr Rheumatol Rep 10:123–130PubMedCrossRef Teng GG, Warriner A, Curtis JR, Saag KG (2008) Improving quality of care in osteoporosis: opportunities and challenges. Curr Rheumatol Rep 10:123–130PubMedCrossRef
19.
Zurück zum Zitat Jaglal SB, Carroll J, Hawker G, McIsaac WJ, Jaakkimainen L, Cadarette SM et al (2003) How are family physicians managing osteoporosis? Qualitative study of their experiences and educational needs. Can Fam Phys 49:462–468 Jaglal SB, Carroll J, Hawker G, McIsaac WJ, Jaakkimainen L, Cadarette SM et al (2003) How are family physicians managing osteoporosis? Qualitative study of their experiences and educational needs. Can Fam Phys 49:462–468
20.
Zurück zum Zitat Naunton M, Peterson GM, Jones G (2006) Pharmacist-provided quantitative heel ultrasound screening for rural women at risk of osteoporosis. Ann Pharmacother 40:38–44PubMedCrossRef Naunton M, Peterson GM, Jones G (2006) Pharmacist-provided quantitative heel ultrasound screening for rural women at risk of osteoporosis. Ann Pharmacother 40:38–44PubMedCrossRef
21.
Zurück zum Zitat Chaiyakunapruk N, Laowakul A, Karnchanarat S, Pikulthong N, Ongphiphadhanakul B (2006) Community pharmacy-based implementation and evaluation of an osteoporosis self-assessment tool for Asians. J Am Pharm Assoc 46:391–396 Chaiyakunapruk N, Laowakul A, Karnchanarat S, Pikulthong N, Ongphiphadhanakul B (2006) Community pharmacy-based implementation and evaluation of an osteoporosis self-assessment tool for Asians. J Am Pharm Assoc 46:391–396
22.
Zurück zum Zitat Law AV, Shapiro K (2005) Impact of a community pharmacist-directed clinic in improving screening and awareness of osteoporosis. J Eval Clin Pract 11:247–255PubMedCrossRef Law AV, Shapiro K (2005) Impact of a community pharmacist-directed clinic in improving screening and awareness of osteoporosis. J Eval Clin Pract 11:247–255PubMedCrossRef
23.
Zurück zum Zitat MacLaughlin EJ, MacLaughlin AA, Snella KA, Winston TS, Fike DS, Raehl CR (2005) Osteoporosis screening and education in community pharmacies using a team approach. Pharmacotherapy 25:379–386PubMedCrossRef MacLaughlin EJ, MacLaughlin AA, Snella KA, Winston TS, Fike DS, Raehl CR (2005) Osteoporosis screening and education in community pharmacies using a team approach. Pharmacotherapy 25:379–386PubMedCrossRef
24.
Zurück zum Zitat Summers KM, Brock TP (2005) Impact of pharmacist-led community bone mineral density screenings. Ann Pharmacother 39:243–248PubMedCrossRef Summers KM, Brock TP (2005) Impact of pharmacist-led community bone mineral density screenings. Ann Pharmacother 39:243–248PubMedCrossRef
25.
Zurück zum Zitat Cerulli J, Zeolla MM (2004) Impact and feasibility of a community pharmacy bone mineral density screening and education program. J Am Pharm Assoc 44:161–167CrossRef Cerulli J, Zeolla MM (2004) Impact and feasibility of a community pharmacy bone mineral density screening and education program. J Am Pharm Assoc 44:161–167CrossRef
26.
Zurück zum Zitat Goode JV, Swiger K, Bluml BM (2004) Regional osteoporosis screening, referral, and monitoring program in community pharmacies: findings from Project ImPACT: Osteoporosis. J Am Pharm Assoc 44:152–160CrossRef Goode JV, Swiger K, Bluml BM (2004) Regional osteoporosis screening, referral, and monitoring program in community pharmacies: findings from Project ImPACT: Osteoporosis. J Am Pharm Assoc 44:152–160CrossRef
27.
Zurück zum Zitat Elliott ME, Meek PD, Kanous NL, Schill GR, Weinswig PA, Bohlman JP et al (2002) Osteoporosis screening by community pharmacists: use of National Osteoporosis Foundation resources. J Am Pharm Assoc 42:101–110CrossRef Elliott ME, Meek PD, Kanous NL, Schill GR, Weinswig PA, Bohlman JP et al (2002) Osteoporosis screening by community pharmacists: use of National Osteoporosis Foundation resources. J Am Pharm Assoc 42:101–110CrossRef
28.
Zurück zum Zitat Lata PF, Binkley NC, Elliott ME (2002) Acceptability of pharmacy-based bone density measurement by women and primary healthcare providers. Menopause 9:449–455PubMedCrossRef Lata PF, Binkley NC, Elliott ME (2002) Acceptability of pharmacy-based bone density measurement by women and primary healthcare providers. Menopause 9:449–455PubMedCrossRef
29.
Zurück zum Zitat Johnson JF, Koenigsfeld C, Hughell L, Parsa RA, Bravard S (2008) Bone health screening, education, and referral project in northwest Iowa: creating a model for community pharmacies. J Am Pharm Assoc 48:379–387CrossRef Johnson JF, Koenigsfeld C, Hughell L, Parsa RA, Bravard S (2008) Bone health screening, education, and referral project in northwest Iowa: creating a model for community pharmacies. J Am Pharm Assoc 48:379–387CrossRef
30.
Zurück zum Zitat McDonough RP, Doucette WR, Kumbera P, Klepser DG (2005) An evaluation of managing and educating patients on the risk of glucocorticoid-induced osteoporosis. Value Health 8:24–31PubMedCrossRef McDonough RP, Doucette WR, Kumbera P, Klepser DG (2005) An evaluation of managing and educating patients on the risk of glucocorticoid-induced osteoporosis. Value Health 8:24–31PubMedCrossRef
32.
Zurück zum Zitat Dillman DA (2000) Mail and Internet surveys: the tailored design method. John Wiley and Sons Inc., New York Dillman DA (2000) Mail and Internet surveys: the tailored design method. John Wiley and Sons Inc., New York
33.
Zurück zum Zitat Krska J, Morecroft CW (2010) Views of the general public on the role of pharmacy in public health. J Pharm Health Serv Res 1:33–38 Krska J, Morecroft CW (2010) Views of the general public on the role of pharmacy in public health. J Pharm Health Serv Res 1:33–38
35.
Zurück zum Zitat Ritchie J, Spencer L (1994) Qualitative data analysis for applied policy research. In: Bryman A, Burgess RG (eds) Analyzing qualitative data, 1st edn. Routledge, New York, pp 173–194CrossRef Ritchie J, Spencer L (1994) Qualitative data analysis for applied policy research. In: Bryman A, Burgess RG (eds) Analyzing qualitative data, 1st edn. Routledge, New York, pp 173–194CrossRef
36.
Zurück zum Zitat Jorgenson D, Lamb D, MacKinnon NJ (2011) Practice change challenges and priorities: a national survey of practising pharmacists. Can Pharm J 144:125–131CrossRef Jorgenson D, Lamb D, MacKinnon NJ (2011) Practice change challenges and priorities: a national survey of practising pharmacists. Can Pharm J 144:125–131CrossRef
37.
Zurück zum Zitat Eades CE, Ferguson JS, O’Carroll RE (2011) Public health in community pharmacy: a systematic review of pharmacist and consumer views. BMC Publ Health 11:582CrossRef Eades CE, Ferguson JS, O’Carroll RE (2011) Public health in community pharmacy: a systematic review of pharmacist and consumer views. BMC Publ Health 11:582CrossRef
38.
Zurück zum Zitat Laliberte MC, Perreault S, Damestoy N, Lalonde L (2012) Ideal and actual involvement of community pharmacists in health promotion and prevention: a cross-sectional study in Quebec, Canada. BMC Publ Health 12:192CrossRef Laliberte MC, Perreault S, Damestoy N, Lalonde L (2012) Ideal and actual involvement of community pharmacists in health promotion and prevention: a cross-sectional study in Quebec, Canada. BMC Publ Health 12:192CrossRef
39.
Zurück zum Zitat Gillespie LD, Robertson MC, Gillespie WJ, Lamb SE, Gates S, Cumming RG et al. (2009) Interventions for preventing falls in older people living in the community. Cochrane Database Syst Rev Issue 2:CD007146 Gillespie LD, Robertson MC, Gillespie WJ, Lamb SE, Gates S, Cumming RG et al. (2009) Interventions for preventing falls in older people living in the community. Cochrane Database Syst Rev Issue 2:CD007146
40.
Zurück zum Zitat Bodenheimer T, Wagner EH, Grumbach K (2002) Improving primary care for patients with chronic illness. JAMA 288:1775–1779PubMedCrossRef Bodenheimer T, Wagner EH, Grumbach K (2002) Improving primary care for patients with chronic illness. JAMA 288:1775–1779PubMedCrossRef
41.
Zurück zum Zitat Wagner EH, Austin BT, Von Korff M (1996) Organizing care for patients with chronic illness. Milbank Q 74:511–544PubMedCrossRef Wagner EH, Austin BT, Von Korff M (1996) Organizing care for patients with chronic illness. Milbank Q 74:511–544PubMedCrossRef
43.
Zurück zum Zitat Jaglal SB, Donescu OS, Bansod V, Laprade J, Thorpe K, Hawker G et al (2012) Impact of a centralized osteoporosis coordinator on post-fracture osteoporosis management: a cluster randomized trial. Osteoporos Int 23:87–95PubMedCrossRef Jaglal SB, Donescu OS, Bansod V, Laprade J, Thorpe K, Hawker G et al (2012) Impact of a centralized osteoporosis coordinator on post-fracture osteoporosis management: a cluster randomized trial. Osteoporos Int 23:87–95PubMedCrossRef
44.
Zurück zum Zitat Adler RA, Bates DW, Dell RM, LeBoff MS, Majumdar SR, Saag KG et al (2011) Systems-based approaches to osteoporosis and fracture care: policy and research recommendations from the workgroups. Osteoporos Int 22(Suppl 3):495–500PubMedCrossRef Adler RA, Bates DW, Dell RM, LeBoff MS, Majumdar SR, Saag KG et al (2011) Systems-based approaches to osteoporosis and fracture care: policy and research recommendations from the workgroups. Osteoporos Int 22(Suppl 3):495–500PubMedCrossRef
45.
Zurück zum Zitat Marsh D, Akesson K, Beaton DE, Bogoch ER, Boonen S, Brandi ML et al (2011) Coordinator-based systems for secondary prevention in fragility fracture patients. Osteoporos Int 22:2051–2065PubMedCrossRef Marsh D, Akesson K, Beaton DE, Bogoch ER, Boonen S, Brandi ML et al (2011) Coordinator-based systems for secondary prevention in fragility fracture patients. Osteoporos Int 22:2051–2065PubMedCrossRef
Metadaten
Titel
The role of community pharmacists in the prevention and management of osteoporosis and the risk of falls: results of a cross-sectional study and qualitative interviews
verfasst von
M.-C. Laliberté
S. Perreault
N. Damestoy
L. Lalonde
Publikationsdatum
01.06.2013
Verlag
Springer-Verlag
Erschienen in
Osteoporosis International / Ausgabe 6/2013
Print ISSN: 0937-941X
Elektronische ISSN: 1433-2965
DOI
https://doi.org/10.1007/s00198-012-2171-y

Weitere Artikel der Ausgabe 6/2013

Osteoporosis International 6/2013 Zur Ausgabe

Arthropedia

Grundlagenwissen der Arthroskopie und Gelenkchirurgie. Erweitert durch Fallbeispiele, Videos und Abbildungen. 
» Jetzt entdecken

Notfall-TEP der Hüfte ist auch bei 90-Jährigen machbar

26.04.2024 Hüft-TEP Nachrichten

Ob bei einer Notfalloperation nach Schenkelhalsfraktur eine Hemiarthroplastik oder eine totale Endoprothese (TEP) eingebaut wird, sollte nicht allein vom Alter der Patientinnen und Patienten abhängen. Auch über 90-Jährige können von der TEP profitieren.

Arthroskopie kann Knieprothese nicht hinauszögern

25.04.2024 Gonarthrose Nachrichten

Ein arthroskopischer Eingriff bei Kniearthrose macht im Hinblick darauf, ob und wann ein Gelenkersatz fällig wird, offenbar keinen Unterschied.

Therapiestart mit Blutdrucksenkern erhöht Frakturrisiko

25.04.2024 Hypertonie Nachrichten

Beginnen ältere Männer im Pflegeheim eine Antihypertensiva-Therapie, dann ist die Frakturrate in den folgenden 30 Tagen mehr als verdoppelt. Besonders häufig stürzen Demenzkranke und Männer, die erstmals Blutdrucksenker nehmen. Dafür spricht eine Analyse unter US-Veteranen.

Ärztliche Empathie hilft gegen Rückenschmerzen

23.04.2024 Leitsymptom Rückenschmerzen Nachrichten

Personen mit chronischen Rückenschmerzen, die von einfühlsamen Ärzten und Ärztinnen betreut werden, berichten über weniger Beschwerden und eine bessere Lebensqualität.

Update Orthopädie und Unfallchirurgie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.